Showing posts with label Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies. Show all posts
Showing posts with label Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies. Show all posts
Saturday, January 23, 2021

FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

›
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ul...